Neurofeedback impacts cognition and quality of life in pediatric focal epilepsy: An exploratory randomized double-blinded sham-controlled trial. LeonMorales-Quezada, DianaMartinez, Mirret M.El-Hagrassy, Ted J.Kaptchuk, M. BarryStermane, Gloria Y.Yehg. 2019.
Children with epilepsy experience cognitive deficits and well-being issues that have detrimental effects on their development. Pharmacotherapy is the standard of care in epilepsy; however, few interventions exist to promote cognitive development and to mitigate disease burden. We aimed to examine the impact of two different modalities of neurofeedback (NFB) on cognitive functioning and quality-of-life (QOL) measurements in children and adolescents with controlled focal epilepsy. The study also explored the effects of NFB on clinical outcomes and electroencephalography (EEG) quantitative analysis.
At Boston NeuroDynamics, we are always looking for new techniques, scientific approaches, and research based practices. This means not only staying up to date with what is happening in the field, but also to conduct our own research studies and collaborate with other professionals around the world.